E&Z acquires cyclotron in the Rhineland

Berlin, (PresseBox) - Eckert & Ziegler AG (ISIN DE0005659700), a specialist for isotope technology applications in medicine and industry, has acquired the radiopharmaceutical manufacturer MC Pharma GmbH. Effective today, the 16 employees and the cyclotron for producing radioactive contrast agents are now part of the Pankow-based Eckert & Ziegler Group, which is continuing to expand its position as a manufacturer of radiopharmaceutical products for new nuclear medical imaging processes.

The contrast agents or "tracers" made in cyclotrons are used in PET scans (Positron Emission Tomography). This new imaging process can diagnose cancer and other diseases very accurately and safely, and is playing an increasingly important role in precisely assessing cancer and monitoring its treatment. Already well established in many European countries, PET scans were just included in the catalogue of treatments remunerated by German state health insurance companies this summer. One of their major uses is in diagnosing lung cancer.

Eckert & Ziegler Strahlen- und Medizintechnik AG

For over forty (40) years, Eckert & Ziegler Isotope Products, (a subsidiary of Eckert & Ziegler AG) has been producing instrumentation and calibration standards. Today it is the world's leading manufacturer for nuclear imaging reference and calibration standards and a leading producer of radioactive components for industrial, scientific and medical applications.

Eckert & Ziegler AG is a global isotope technology company that processes radioisotopes as well as develops, manufactures and sells isotope technology components, medical technology equipment and related products.

Eckert & Ziegler employs over 430 people worldwide. Throughout all of its subsidiaries it generates yearly consolidated revenues in excess of $ 83 MM(54 Mio. EUR). Eckert & Ziegler AG is listed in the Prime Standard of the German Stock Exchange in Frankfurt am Main (ISIN DE0005659700).

Press releases you might also be interested in

Subscribe for news

The subscribtion service of the PresseBox informs you about press information of a certain topic by your choice at a choosen time. Please enter your email address to receive the email with the press releases.

An error occurred!

Thank you! You will receive a confirmation email within a few minutes.


I want to subscribe to the gratis press mail and have read and accepted the conditions.